7146e3a33d4c3c27…
OutcomeID:
NCT00082602-outcome-0277 bytesFirst seen Jun 12, 20261 collectionFields
| Name | Value |
|---|---|
| description | null |
| studyId | NCT00082602 |
| timeFrame | null |
| title | The primary end point occurs at Week 8. The primary outcome measures will be tolerability and safety through rates of adverse events. |
| type | primary |
Canonical JSON
{
"id": "NCT00082602-outcome-0",
"type": "Outcome",
"data": {
"description": null,
"studyId": "NCT00082602",
"timeFrame": null,
"title": "The primary end point occurs at Week 8. The primary outcome measures will be tolerability and safety through rates of adverse events.",
"type": "primary"
}
}Appears in 1 collection
nih/clinical-trials1 version · Jun 12, 2026
Full hash:7146e3a33d4c3c279ea7b4c1f99642fe0cf71c827864e537e1e2ed87cb537810